Evidence map›Paper›PMID 33747068›Full record

ArticleThe journal of venomous animals and toxins including tropical diseases2021

Annelize Zambon Barbosa Aragão, Natália Galdi Quel, Paulo Pinto Joazeiro, Tomomasa Yano

Open access · goldAbstract read
In one paragraph

Article in The journal of venomous animals and toxins including tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Annelize Zambon Barbosa AragãoDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, State University of Campinas (Unicamp), Campinas, SP, Brazil.ORCID 0000-0002-8298-6031
Natália Galdi QuelDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, State University of Campinas (Unicamp), Campinas, SP, Brazil.
Paulo Pinto JoazeiroDepartment of Biochemistry and Tissue Biology, Institute of Biology, State University of Campinas (Unicamp), Campinas, SP, Brazil.
Tomomasa YanoDepartment of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, State University of Campinas (Unicamp), Campinas, SP, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAvian pathogenic

methodsWe investigated the intracellular activities of ECVF in avian fibroblasts using fluorescence staining, electron microscopy, MTT and LDH measurements. As ECVF act specifically in avian cells, we performed blotting assay followed by mass spectrometry to better understand its initial intracellular protein recognition.

resultsECVF induced actin contraction, mitochondrial damage and membrane permeability alterations. Ultrastructural analysis showed intracellular alterations, as nuclear lobulation and the presence of degraded structures inside the vacuoles. Moreover, ECVF induced cell death in fibroblasts. ECVF-biotin associates to at least two proteins only in avian cell lysates: alpha-actinin 4 and vinculin, both involved in cytoskeleton structure.

conclusionThese findings demonstrated that ECVF plays an important role in avian cellulitis, markedly in initial steps of infection. Taken together, the results place this toxin as a target for drug and/or vaccine development, instead of the use of large amounts antibiotics.

Indexed as

Avian pathogenic Escherichia coli (APEC)CytoskeletonEscherichia coliEscherichia coli vacuolating factor (ECVF)

Identifiers

PMID33747068
PMCPMC7941731
OpenAlexW3134227005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.